Beyond Celiac Outlines Plan to Accelerate a Celiac Disease Cure by 2030
Strategic science plan to change the future for the 3.2 million Americans living with this serious genetic autoimmune disorder
May 13, 2021 10:35 ET | Source: Beyond Celiac Beyond Celiac Ambler, Pennsylvania, UNITED STATES
Philadelphia, PA, May 13, 2021 (GLOBE NEWSWIRE) Beyond Celiac, the leading catalyst for a celiac disease cure in the United States, is celebrating Celiac Awareness Month this month with a laser-focus on its mission to advance the science of celiac disease. Outlined in its strategic science plan developed
under the leadership of Chief Scientist and Strategy Officer Salvatore (Salvo) Alesci, MD, PhD, the organization is committed to addressing the many current barriers to a cure through four scientific priorities: evidence generation, translational research, clinical trials and drug repurposing.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Beyond Celiac Announces a Research Grant Program with Janssen to Support Critical Research into .
Beyond CeliacFebruary 16, 2021 GMT
Salvatore (Salvo) Alesci, MD, PhD, Chief Scientist and Strategy Officer and Ken Kilgore, PhD, MBA, Chief Scientific Investment Officer
Salvatore (Salvo) Alesci, MD, PhD, Chief Scientist and Strategy Officer and Ken Kilgore, PhD, MBA, Chief Scientific Investment Officer
Philadelphia, PA, Feb. 16, 2021 (GLOBE NEWSWIRE) Beyond Celiac, the leading catalyst for a celiac disease cure in the United States, today announced a two-year joint research grant program with Janssen Research & Development, LLC (Janssen) through its World Without Disease Accelerator group. Through a commitment of up to $1 million in funds and services, Beyond Celiac together with Janssen will co-fund research focusing on risk detection, prevention, interception and cure of celiac diseas